Details

Structural aspects of Mycobacterium tuberculosis DNA gyrase targeted by novel bacterial topoisomerase inhibitors
ID Kokot, Maja (Author), ID Hrast, Martina (Author), ID Feng, Lipeng (Author), ID Mitchenall, Lesley A (Author), ID Lawson, David M. (Author), ID Maxwell, Anthony (Author), ID Parish, Tanya (Author), ID Minovski, Nikola (Author), ID Anderluh, Marko (Author)

.pdfPDF - Presentation file, Download (6,47 MB)
MD5: F9AE93CDB8CB4E1CEA8BA539B1EA29F5
URLURL - Source URL, Visit https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00447 This link opens in a new window

Abstract
In this Letter, we present a small series of novel bacterial topoisomerase inhibitors (NTBIs) that exhibit both potent inhibition of Mycobacterium tuberculosis DNA gyrase and potent antimycobacterial activity. The disclosed crystal structure of M. tuberculosis DNA gyrase in complex with DNA and compound 5 from this NBTI series reveals the binding mode of an NBTI in the GyrA binding pocket and confirms the presence and importance of halogen bonding for the excellent on-target potency. In addition, we have shown that compound 5 is a promising M. tuberculosis DNA gyrase inhibitor, with an IC$_{50}$ for M. tuberculosis gyrase of 0.096 μM, and it has potent activity against M. tuberculosis, with an IC$_{50}$ of 0.165 μM.

Language:English
Keywords:NBTIs, DNA gyrase, M. tuberculosis, crystal structure, bifurcated halogen bonds
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 2164−2170
Numbering:Vol. 15, iss. 12
PID:20.500.12556/RUL-165967 This link opens in a new window
UDC:615.4:54:616-002.5
ISSN on article:1948-5875
DOI:10.1021/acsmedchemlett.4c00447 This link opens in a new window
COBISS.SI-ID:215946755 This link opens in a new window
Publication date in RUL:16.12.2024
Views:229
Downloads:77
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:ACS Medicinal Chemistry Letters
Publisher:American Chemical Society
ISSN:1948-5875
COBISS.SI-ID:2959217 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:DNA giraza, Mycobacterium tuberculosis, inhibitorji, bakterijske topoizomeraze, farmacevtska kemija, tuberkuloza

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0017
Name:Modeliranje kemijskih procesov in lastnosti spojin

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Funding programme:Young researchers
Project number:39010

Funder:UKRI - UK Research and Innovation
Funding programme:Biotechnology and Biosciences Research Council, Institute Strategic Programme
Project number:BB/P012523/1

Funder:UKRI - UK Research and Innovation
Funding programme:Biotechnology and Biological Sciences Research Council
Project number:BB/V006983/1

Funder:ARRS - Slovenian Research Agency
Project number:BI-US/22-25-151

Funder:NIH - National Institutes of Health
Funding programme:National Institute of Allergy and Infectious Diseases
Project number:P30AI168034
Name:Seattle Tuberculosis Research Advancement Center
Acronym:SEATRAC

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back